14 Nov, EOD - Indian

SENSEX 77580.31 (-0.14)

Nifty 50 23532.7 (-0.11)

Nifty Bank 50179.55 (0.18)

Nifty IT 42390.85 (0.05)

Nifty Midcap 100 54043.1 (0.45)

Nifty Next 50 67408.65 (0.46)

Nifty Pharma 21752 (-0.26)

Nifty Smallcap 100 17601.05 (0.81)

14 Nov, EOD - Global

NIKKEI 225 38642.91 (0.28)

HANG SENG 19426.34 (-0.05)

S&P 5912 (0.06)

Login/Signup
LOGIN HERE
Cancel

Brooks Laboratories Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 533543 | NSE Symbol : BROOKS | ISIN : INE650L01011 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
06-Nov-2024 09-Nov-2024 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting under Regulation 30 & Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement dated on 09.11.2024)
06-Aug-2024 14-Aug-2024 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended on June 30 2024
07-Aug-2024 07-Aug-2024 Change in Directors Appointment of Additional Independent Director(s).
12-May-2024 18-May-2024 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024. Financial Results for Quarter and Financial Year ended March 31,2024 (As Per BSE Announcement Dated on 18.05.2024)
24-Jan-2024 31-Jan-2024 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results. Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 31/01/2024)
16-Jan-2024 24-Jan-2024 Right Issue BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue. The Board Meeting to be held on 24/01/2024 Stands Cancelled. Further to our letter dated January 16, 2024, intimating the exchange about the Board Meeting to be held on January 24, 2024, we further wish to inform that the agenda items are amended as below: (As per BSE Announcement Dated on 17/01/2024) Issue Of Warrants & Preferential Issue of shares & Rights Issue (As per BSE Bulletin dated on 17/01/2024) Outcome of Board Meeting (As Per BSE Announcement dated on 24.01.2024)
31-Oct-2023 09-Nov-2023 Half Yearly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the Half year and quarter ended September 30 2023. Outcome of Board Meeting Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September,2023 along with Review Report issued by M/s J C Ranpura & Co. Chartered Accountant for the quarter /half year ended 30th September,2023 Financial Results for September 30, 2023 (As Per BSE Announcement Dated on 09/11/2023)
23-Aug-2023 23-Aug-2023 Change in Directors Appointment of Mr. Bhushan Singh Rana as an Additional Director (Executive) of the Company.
02-Aug-2023 10-Aug-2023 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Intimation of Board Meeting to be held on 10th August 2023 for approving unaudited financials for the 1st quarter ended 30th June2023. Outcome of Board Meeting for approval of unaudited quarterly results for June 30,2023 (As Per BSE Announcement dated on 10.08.2023)
03-Jul-2023 18-Jul-2023 Right Issue BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2023 inter alia to consider and approve 1. the issue price and issue size for the proposed Right Issue. 2. the Exchange Ratio / Rights entitlement ratio for the proposed Right Issue. 3. To fix Record Date to ascertain the eligible shareholders for the proposed Right Issue. 4. To determine issue opening date issue closing date and last date for market renunciation. 5. Taking on record and adopting the Letter of Offer (LOF) along with the Abridged Letter of Offer (ALOF) Rights Entitlement Letter (REL) Composite Application Form (CAF). 6. Any other matter incidental and connected to Right Issue. Board Meeting Intimation for Rescheduling Of Meeting To July 18, 2023 BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2023 ,inter alia, to consider and approve matters related to rights issue. (As Per BSE Bulletin dated on 10.07.2023) Outcome of the meeting of the Board of Directors held on July 18, 2023 for determination of Rights Issue matters. (As per BSE Announcement Dated on 18/07/2023)
20-May-2023 29-May-2023 Accounts BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended March 31 2023. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2023. (As Per BSE Announcement dated on 29.05.2023)
03-Feb-2023 14-Feb-2023 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2022. Outcome of Board Meeting for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022 Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022 (As per BSE Announcement Dated on 14/02/2023)
19-Jan-2023 25-Jan-2023 Right Issue BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 inter alia to consider and approve Right Issue of Equity Shares and Postal Ballot Notice Outcome of Board Meeting for approval of Rights Issue and Postal Ballot Notice (As per BSE Announcement Dated on 25/01/2023) Revised outcome of Board meeting dated 25th January, 2023 (As Per BSE Announcement dated on 27.01.2023)
23-Nov-2022 23-Nov-2022 Change in Directors Appointment of Mr. Jitendra Pratap Singh (DIN No. 09796568) as an Additional Director of the Company.
05-Nov-2022 14-Nov-2022 Quarterly Results BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Intimation of Board Meeting to be held on 14th November 2022 inter alia to consider and approve Standalone and Consolidated Financials for the 2nd Quarter ended 30th September 2022 Unaudited Standalone and Consolidated financials for the half year ended 30th September 2022 Standalone and Consolidated unaudited financials for the half year ended 30th September 2022 (As Per BSE Announcement Dated on 14.11.2022)
1 2 3